S Parenti Selected Research

1- (4- amino- 3,5- dimethylphenyl)- 3,5- dihydro- 7,8- ethylenedioxy- 4H- 2,3- benzodiazepin- 4- one

5/2016

A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Parenti Research Topics

Disease

1	Leukemia 05/2016
1	Neoplasms (Cancer) 05/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Rectal Neoplasms (Rectal Cancer) 01/2010

Drug/Important Bio-Agent (IBA)

2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2016 - 01/2010
1	1- (4- amino- 3,5- dimethylphenyl)- 3,5- dihydro- 7,8- ethylenedioxy- 4H- 2,3- benzodiazepin- 4- oneIBA 05/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2016
1	AMPA Receptors (AMPA Receptor)IBA 05/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 05/2016
1	Glutamic Acid (Glutamate)FDA Link 05/2016
1	CateninsIBA 01/2016
1	beta CateninIBA 01/2010

Therapy/Procedure

1	Chemoprevention 01/2010